[Chronochemotherapy].
Dogliotti
L
L
Università degli Studi di Torino, Oncologia Medica ASO San Luigi, Orbassano, TO. luigi.dogliotti@unito.it
Garufi
C
C
Iacobelli
S
S
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D002909:Chronobiology Phenomena; D019454:Chronotherapy / Q000379:methods / Q000592:standards; D017326:Clinical Trials, Phase III as Topic; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D000077150:Oxaliplatin
D000964:Antimetabolites, Antineoplastic; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil